Newly released data from the U.S. Census Bureau shows most Americans still rely on work for their health coverage, with 53.8% of insured Americans receiving coverage through their employer.
In a Harris Poll, the vast majority (84%) of frontline healthcare workers expressed dissatisfaction with their jobs, though most said they’d consider staying in their current role if provided an opportunity for education and career advancement.
The balloon-free catheter, which already had a successful launch in the United States, has been associated with positive outcomes and the ability to reach certain lesions more accurately than balloon-based IVL platforms.
Anders Gilberg, senior vice president of government affairs at the Medical Group Management Association, explains the political and patient care issues involved with ending Affordable Care Act subsidies.
Heart teams continue to play a major role at hospitals and health systems all over the world. Cardiac imagers who have trained in multiple modalities can provide those teams with a significant amount of value.
The FDA’s decision arrived just days after Apple announced the new feature. "This tool empowers patients and clinicians to work together, putting prevention at the center of care," one cardiologist told Cardiovascular Business.
Safety concerns with certain Boston Scientific leads have resulted in multiple Class I recalls, the FDA has announced. The agency first shared a warning about this issue in August.
The findings, based on data from more than 800 TAVR patients, suggest that skipping OAC medications for a small amount of time could make a big impact.
Newly released data from the U.S. Census Bureau shows most Americans still rely on work for their health coverage, with 53.8% of insured Americans receiving coverage through their employer.
In a Harris Poll, the vast majority (84%) of frontline healthcare workers expressed dissatisfaction with their jobs, though most said they’d consider staying in their current role if provided an opportunity for education and career advancement.
The balloon-free catheter, which already had a successful launch in the United States, has been associated with positive outcomes and the ability to reach certain lesions more accurately than balloon-based IVL platforms.
